Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.33 EUR | +2.33% |
|
+1.32% | +12.92% |
Jun. 20 | European Equities Traded in the US as American Depositary Receipts Retreat Friday | MT |
Jun. 19 | Grifols Says Positive Fibrinogen Phase 3 Trial Results Published | RE |
Evolution of the Average Target: Grifols, S.A.
Evolution of the Target Price: Grifols, S.A.
Changes in Analyst Recommendations: Grifols, S.A.
981bd1a13b20f713c8ab2a31c26dd.HMR9uQ0idWWhjz-EMpShfNiAw-taXCg73_Up2GFxNsk.VZcS7T9mMxbt9kj3V9_AG-HJtNwXEUBe54xRvAgmcf9O6RfaXFU3Kvbtag~c4be3df2074b1e2595a282fe701b3eb4
More recommendations
Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+54.52% | ||||||
+30.87% | ||||||
+29.81% | ||||||
+33.45% | ||||||
+35.35% | ||||||
-9.14% | ||||||
+44.87% | ||||||
- | - | - | ||||
+9.77% | ||||||
- | - | -14.41% | ||||
Average | +23.90% | |||||
Weighted average by Cap. | +27.07% |
Analysts' Consensus
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.33EUR
Average target price
15.96EUR
Spread / Average Target
+54.52%
High Price Target
24.00EUR
Spread / Highest target
+132.33%
Low Price Target
9.000EUR
Spread / Lowest Target
-12.88%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
alphavalue | Abhishek Raval |
Invest Securities | |
JPMorgan Chase | |
Credit Suisse | |
Morgan Stanley | |
Citigroup | |
Deutsche Bank Securities | |
HSBC |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GRF Stock
- Consensus Grifols, S.A.
Select your edition
All financial news and data tailored to specific country editions